🇦🇺 ENJAYMO in Australia

ENJAYMO (SUTIMLIMAB-JOME) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: likely_approved

ENJAYMO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Australia

Frequently asked questions

Is ENJAYMO approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for ENJAYMO in Australia?

RECORDATI RARE DISEASES, INC. is the originator. The local marketing authorisation holder may differ — check the official source linked above.